Quick Answer
Axogen, Inc. reported Diluted EPS of $0.34 per share (loss) for fiscal year 2025.
Axogen, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.34 | -47.8% |
| 2024 | -$0.23 | +54.9% |
| 2023 | -$0.51 | +26.1% |
| 2022 | -$0.69 | -6.2% |
| 2021 | -$0.65 | -8.3% |
| 2020 | -$0.60 | +18.9% |
| 2019 | -$0.74 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.01 | +125.0% | +0.0% |
| June 30, 2025 | $0.01 | +125.0% | +112.5% |
| March 31, 2025 | -$0.08 | +46.7% | -100.0% |
| September 30, 2024 | -$0.04 | +60.0% | +0.0% |
| June 30, 2024 | -$0.04 | +75.0% | +73.3% |
| March 31, 2024 | -$0.15 | +11.8% | -50.0% |
| September 30, 2023 | -$0.10 | +0.0% | +37.5% |
| June 30, 2023 | -$0.16 | +11.1% | +5.9% |
- Axogen, Inc. showed a decrease of -47.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, Axogen, Inc.’s diluted eps has grown by 54.1% (from $0.74 per share (loss) to $0.34 per share (loss)).
- The most recent figure is from Axogen, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: